Year archive

Anteris Technologies Global Corp. — 2013 filings

All 84 regulatory filings released by Anteris Technologies Global Corp. (AVR) in 2013, sourced directly from the official regulator.

84 Filings

2013 Period

2013 filings (84)

Filing	Released	Lang
Admedus End of Year Update 3 pages 279.9KB Regulatory Filings	2013-12-23	English
Change of Director's Interest Notice - Correction 3 pages 310.7KB Regulatory Filings	2013-12-17	English
Appendix 3B & Notice under Section 708A 14 pages 676.5KB Regulatory Filings	2013-12-16	English
Change of Director's Interest Notices 10 pages 311.5KB Regulatory Filings	2013-12-16	English
Admedus Acquires Manufacturing Facility 2 pages 224.4KB Regulatory Filings	2013-12-11	English
Change of Company Name 1 page 189.6KB Regulatory Filings	2013-11-20	English
Chairman's Address to Shareholders 3 pages 110.9KB Regulatory Filings	2013-11-19	English
Presentation to Shareholders 26 pages 4.9MB Regulatory Filings	2013-11-19	English
Results of Meeting 2 pages 107.5KB Regulatory Filings	2013-11-19	English
Allied makes first sale of CardioCel into Europe 2 pages 183.8KB Regulatory Filings	2013-11-07	English
Change in substantial holding 2 pages 583.4KB Regulatory Filings	2013-11-03	English
Appendix 3B - Options & Notice under Section 708A 15 pages 781.4KB Regulatory Filings	2013-11-03	English
Allied awarded Industry's Emerging Company of the Year 3 pages 289.0KB Regulatory Filings	2013-10-30	English
Appendix 4C - quarterly 7 pages 454.1KB Regulatory Filings	2013-10-30	English
Appendix 3B - Rights Issue 13 pages 696.4KB Regulatory Filings	2013-10-24	English
Change of Director's Interest Notices 10 pages 307.9KB Regulatory Filings	2013-10-24	English
Top 20 securityholders 1 page 259.4KB Regulatory Filings	2013-10-24	English
Change in substantial holding 3 pages 786.6KB Regulatory Filings	2013-10-24	English
Response to ASX price query 4 pages 335.4KB Regulatory Filings	2013-10-24	English
Allied completes oversubscribed $10.4 million Rights Issue 3 pages 201.9KB Regulatory Filings	2013-10-22	English
Waiver to Listing Rule 10.13.5 2 pages 269.9KB Regulatory Filings	2013-10-21	English
Notice of Annual General Meeting 43 pages 664.0KB Regulatory Filings	2013-10-20	English
Proxy Form 2 pages 341.9KB Regulatory Filings	2013-10-20	English
Full Annual Report to shareholders 80 pages 5.2MB Regulatory Filings	2013-10-20	English
Allied Herpes Phase I Trial progress update 2 pages 271.2KB Regulatory Filings	2013-10-16	English
8 Surgeons get approval to use CardioCel in adult patients 2 pages 198.4KB Regulatory Filings	2013-10-07	English
Appendix 3B - Exercise of Options 14 pages 694.7KB Regulatory Filings	2013-10-07	English
Dispatch of Offer Document 1 page 199.5KB Regulatory Filings	2013-10-02	English
Appendix 3B - Exercise of Options 14 pages 694.9KB Regulatory Filings	2013-09-26	English
Change of Director's Interest Notice 2 pages 218.5KB Regulatory Filings	2013-09-26	English
5 year extension data for Allied's CardioCel 2 pages 288.9KB Regulatory Filings	2013-09-24	English
Notice under Section 708AA 2 pages 192.2KB Regulatory Filings	2013-09-22	English
Allied announces fully underwritten Rights Issue 4 pages 310.1KB Regulatory Filings	2013-09-22	English
Non-Renounceable Issue Offer Document 30 pages 491.9KB Regulatory Filings	2013-09-22	English
Appendix 3B - Rights Issue 12 pages 544.4KB Regulatory Filings	2013-09-22	English
Letter to Optionholders 2 pages 120.4KB Regulatory Filings	2013-09-22	English
Letter to Eligible Shareholders 3 pages 122.2KB Regulatory Filings	2013-09-22	English
Letter to Ineligible Shareholders 2 pages 114.5KB Regulatory Filings	2013-09-22	English
Exercise of Options 14 pages 693.8KB Regulatory Filings	2013-09-17	English
Investor Presentation 30 pages 1.2MB Regulatory Filings	2013-09-10	English
Appendix 3B - Exercise of Options 14 pages 708.7KB Regulatory Filings	2013-09-10	English
Appendix 3B - Exercise of Options 14 pages 694.5KB Regulatory Filings	2013-09-05	English
Appendix 3B - Exercise of Options 14 pages 693.7KB Regulatory Filings	2013-09-03	English
Allied Herpes Vaccine Phase I Trial Update 2 pages 194.4KB Regulatory Filings	2013-09-02	English
Appendix 3B - Exercise of Options 14 pages 605.8KB Regulatory Filings	2013-08-29	English
Annual Report to shareholders and Appendix 4E 62 pages 1.8MB Regulatory Filings	2013-08-29	English
Appendix 3B - Exercise of Options 14 pages 694.3KB Regulatory Filings	2013-08-26	English
Cancellation of Unlisted Options 1 page 175.9KB Regulatory Filings	2013-08-26	English
Allied granted CE Mark for CardioCel 3 pages 200.2KB Regulatory Filings	2013-08-25	English
Response to ASX price query 5 pages 341.7KB Regulatory Filings	2013-08-19	English
Appendix 4C - quarterly 7 pages 455.2KB Regulatory Filings	2013-07-29	English
Change in substantial holding 2 pages 92.0KB Regulatory Filings	2013-07-29	English
Shareholder Newsletter - June 2013 4 pages 152.6KB Regulatory Filings	2013-07-10	English
Adult Surgeon approved to use Allied's CardioCel 2 pages 197.3KB Regulatory Filings	2013-07-07	English
Appendix 3B 14 pages 705.1KB Regulatory Filings	2013-07-07	English
Section 708A Notice 1 page 136.3KB Regulatory Filings	2013-07-07	English
Replacement - Appendix 3B 14 pages 704.6KB Regulatory Filings	2013-07-07	English
Allied increases stake in Ian Frazer's Coridon vaccines 2 pages 196.1KB Regulatory Filings	2013-06-30	English
Ceasing to be a substantial holder 2 pages 472.4KB Regulatory Filings	2013-06-19	English
Appendix 3B - ESOP 14 pages 704.7KB Regulatory Filings	2013-06-19	English
Allied's Herpes Vaccine Progresses to Phase 1 Clinical Trial 2 pages 180.8KB Regulatory Filings	2013-06-18	English
Change in substantial holding 3 pages 874.2KB Regulatory Filings	2013-06-04	English
Allied's CardioCel receives $1.9M grant 3 pages 224.5KB Regulatory Filings	2013-06-02	English
Allied's CardioCel in Spotlight at International Conferences 3 pages 201.0KB Regulatory Filings	2013-05-05	English
Appendix 3B - Options 14 pages 704.3KB Regulatory Filings	2013-05-01	English
Appendix 4C - quarterly 7 pages 456.8KB Regulatory Filings	2013-04-28	English
Allied Announces Additional Early Access for CardioCel 3 pages 278.6KB Regulatory Filings	2013-04-07	English
Allied lodges 510(k) with FDA for CardioCel 3 pages 201.7KB Regulatory Filings	2013-04-01	English
Shareholder Newsletter - March 2013 4 pages 882.1KB Regulatory Filings	2013-03-26	English
Clinical Trial Extension Study Update - No Calcification 3 pages 200.9KB Regulatory Filings	2013-03-05	English
Half Yearly Report 24 pages 128.8KB Regulatory Filings	2013-02-21	English
Response to ASX query 5 pages 362.5KB Regulatory Filings	2013-02-18	English
Replacement form - Change in substantial holding 2 pages 132.3KB Regulatory Filings	2013-02-14	English
Allied announces ISO 13485 certification for CardioCel 3 pages 200.8KB Regulatory Filings	2013-02-12	English
Ceasing to be a substantial holder 2 pages 147.8KB Regulatory Filings	2013-02-10	English
Amended form - change in substantial holding 2 pages 867.9KB Regulatory Filings	2013-02-06	English
Allied's CardioCel superior for seeding stem cells 5 pages 712.5KB Regulatory Filings	2013-02-05	English
Change in substantial holding 7 pages 1.3MB Regulatory Filings	2013-02-03	English
Appendix 4C - quarterly 6 pages 436.9KB Regulatory Filings	2013-01-29	English
Appendix 3B - Share Purchase Plan 15 pages 727.8KB Regulatory Filings	2013-01-28	English
Top 20 securityholders 1 page 228.4KB Regulatory Filings	2013-01-28	English
Change of Director's Interest Notices 8 pages 293.8KB Regulatory Filings	2013-01-28	English
Allied closes SPP, bringing total capital raised to $4.6M 2 pages 268.3KB Regulatory Filings	2013-01-22	English
Allied's hernia and pelvic floor results 3 pages 280.0KB Regulatory Filings	2013-01-09	English

Filings by year

2026 56 filings
2025 175 filings
2024 164 filings
2023 132 filings
2022 104 filings
2021 118 filings
2020 26 filings
2019 59 filings
2018 84 filings
2017 48 filings
2016 74 filings
2015 79 filings
2014 54 filings
2013 84 filings
2012 65 filings
2011 34 filings
2010 46 filings
2009 49 filings
2008 28 filings
2007 64 filings
2006 31 filings
2005 26 filings
2004 60 filings